Howard W Robin - Net Worth and Insider Trading
Howard W Robin Net Worth
The estimated net worth of Howard W Robin is at least $4 Million dollars as of 2026-08-09. Howard W Robin is the President & CEO of Nektar Therapeutics and owns about 55,073 shares of Nektar Therapeutics (NKTR) stock worth over $4 Million. Details can be seen in Howard W Robin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Howard W Robin has not made any transactions after 2026-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Howard W Robin
Howard W Robin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Howard W Robin owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of Howard W Robin’s form 4 insider trades.
Insider Ownership Summary of Howard W Robin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2026-06-17 | director & President & CEO |
Howard W Robin Latest Holdings Summary
Howard W Robin currently owns a total of 1 stock. Howard W Robin owns 55,073 shares of Nektar Therapeutics (NKTR) as of June 17, 2026, with a value of $4 Million.
Latest Holdings of Howard W Robin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2026-06-17 | 55,073 | 76.48 | 4,211,983 |
Holding Weightings of Howard W Robin
Howard W Robin Form 4 Trading Tracker
According to the SEC Form 4 filings, Howard W Robin has made a total of 25 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Nektar Therapeutics is the sale of 20,000 shares on June 17, 2026, which brought Howard W Robin around $1 Million.
Insider Trading History of Howard W Robin
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Howard W Robin Trading Performance
Howard W Robin Ownership Network
Ownership Network List of Howard W Robin
Ownership Network Relation of Howard W Robin

Howard W Robin Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Howard W Robin is the director & President & CEO of Nektar Therapeutics. Other key executives at Nektar Therapeutics include Chief R&D Officer Jonathan Zalevsky , Interim CFO Linda M Rubinstein , and Chief Legal Officer Mark Andrew Wilson .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Howard W Robin made 10 insider transaction in Nektar Therapeutics (NKTR) with a net sale of 91,627. Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 40,565 shares made by Jonathan Zalevsky , a net sale of 22,342 shares made by Mark Andrew Wilson ,
In summary, during the past 3 months, insiders sold 31,862 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 31,862 shares. During the past 18 months, 71,439 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,439 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Howard W Robin Mailing Address
Above is the net worth, insider trading, and ownership report for Howard W Robin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Howard W Robin's mailing address is: San Francisco Ca 94158.